
DSIP Peptide 2mg in 2ml
Naturally occurring hypothalamic neuropeptide that induces deep delta-wave sleep, normalises cortisol, and enhances growth hormone release during sleep — without sedation or dependency.
Full Details & Dosage GuideDSIP (Delta Sleep-Inducing Peptide) is a neuropeptide naturally produced in the hypothalamus that plays a critical role in sleep regulation, stress adaptation, and neuroendocrine function. First isolated in 1974 from rabbit blood during deep delta-wave sleep, it crosses the blood-brain barrier to act on GABA-B and δ-opioid receptors — inducing natural slow-wave sleep without suppressing REM, while simultaneously lowering cortisol and synchronising GH pulses to deep sleep phases.
Clinical Uses
- Sleep architecture improvement (delta/slow-wave sleep)
- Chronic insomnia & sleep disorders
- Stress & cortisol dysregulation
- GH release during sleep enhancement
- Opiate withdrawal support
- Chronic pain management
- Circadian rhythm restoration
Key Benefits
- Induces natural delta-wave (deep) sleep
- Reduces cortisol and stress hormone levels
- Enhances GH release during sleep naturally
- Anti-oxidant properties
- Analgesic effects (pain reduction)
- Improves sleep quality without sedation or dependency
- Supports neuroendocrine balance
How It Works
DSIP crosses the blood-brain barrier and acts on GABA-B receptors and δ-opioid receptors in the hypothalamus and limbic system. It modulates the sleep-wake cycle by increasing slow-wave (delta) sleep without reducing REM sleep. It simultaneously suppresses CRH (corticotropin-releasing hormone), reducing cortisol secretion, and synchronises GH pulses to coincide with deep sleep phases.
Dosage Protocol
Standard: 100–500 mcg subcutaneous before bed. Combined stack: 100 mcg DSIP + CJC 100 mcg + Ipamorelin 200 mcg for maximum sleep/recovery. Do not use daily — 2–3× per week maximum.
When to Expect Results
First night: noticeable sleep depth improvement. 1–2 weeks: cortisol pattern normalisation. 3–4 weeks: full sleep architecture restoration.

Selank 7.5mg
Russian anxiolytic peptide — stress relief, focus & memory enhancement
Full Details & Dosage GuideClinical Uses
- Generalized anxiety disorder
- Cognitive performance enhancement
- Memory consolidation and learning
- Post-stress neurological recovery
- ADHD-like focus and attention deficits
- Mild depression support
Key Benefits
- Anxiolytic without sedation — anxiety reduction with full mental clarity
- Enhances BDNF (brain-derived neurotrophic factor) production
- Improves working memory and verbal fluency
- Modulates serotonin and dopamine balance without dependency
- Non-habit-forming with no withdrawal syndrome
- Compatible with long-term use in clinical trials
How It Works
Selank is a synthetic hexapeptide analog of tuftsin. It acts on the benzodiazepine-GABA receptor complex to produce anxiolytic effects without sedation or tolerance. It also upregulates BDNF expression, increases enkephalin degradation (reducing anxiety signals), and modulates serotonin, dopamine, and norepinephrine balance.
Dosage Protocol
250–500 mcg intranasal spray 2–3x daily. Alternatively: 250–500 mcg subcutaneous injection once daily. Nasal route preferred for faster CNS delivery. Typical course: 2–4 weeks acute, 3 months maintenance.
When to Expect Results
Day 1–3: reduced anxiety and improved emotional regulation. Week 1–2: enhanced focus, memory consolidation, and stress resilience. Week 3–6: sustained cognitive improvement and mood stabilization. Long-term: improved BDNF levels and neuroprotection.

Selank 30mg
Nasal Selank — rapid anxiolytic and cognitive enhancement
Full Details & Dosage GuideClinical Uses
- Generalized anxiety disorder
- Cognitive performance enhancement
- Memory consolidation and learning
- Post-stress neurological recovery
- ADHD-like focus and attention deficits
- Mild depression support
Key Benefits
- Anxiolytic without sedation — anxiety reduction with full mental clarity
- Enhances BDNF (brain-derived neurotrophic factor) production
- Improves working memory and verbal fluency
- Modulates serotonin and dopamine balance without dependency
- Non-habit-forming with no withdrawal syndrome
- Compatible with long-term use in clinical trials
How It Works
Selank is a synthetic hexapeptide analog of tuftsin. It acts on the benzodiazepine-GABA receptor complex to produce anxiolytic effects without sedation or tolerance. It also upregulates BDNF expression, increases enkephalin degradation (reducing anxiety signals), and modulates serotonin, dopamine, and norepinephrine balance.
Dosage Protocol
250–500 mcg intranasal spray 2–3x daily. Alternatively: 250–500 mcg subcutaneous injection once daily. Nasal route preferred for faster CNS delivery. Typical course: 2–4 weeks acute, 3 months maintenance.
When to Expect Results
Day 1–3: reduced anxiety and improved emotional regulation. Week 1–2: enhanced focus, memory consolidation, and stress resilience. Week 3–6: sustained cognitive improvement and mood stabilization. Long-term: improved BDNF levels and neuroprotection.

Selank 75mg
Large-volume nasal Selank for extended anxiolytic protocol
Full Details & Dosage GuideClinical Uses
- Generalized anxiety disorder
- Cognitive performance enhancement
- Memory consolidation and learning
- Post-stress neurological recovery
- ADHD-like focus and attention deficits
- Mild depression support
Key Benefits
- Anxiolytic without sedation — anxiety reduction with full mental clarity
- Enhances BDNF (brain-derived neurotrophic factor) production
- Improves working memory and verbal fluency
- Modulates serotonin and dopamine balance without dependency
- Non-habit-forming with no withdrawal syndrome
- Compatible with long-term use in clinical trials
How It Works
Selank is a synthetic hexapeptide analog of tuftsin. It acts on the benzodiazepine-GABA receptor complex to produce anxiolytic effects without sedation or tolerance. It also upregulates BDNF expression, increases enkephalin degradation (reducing anxiety signals), and modulates serotonin, dopamine, and norepinephrine balance.
Dosage Protocol
250–500 mcg intranasal spray 2–3x daily. Alternatively: 250–500 mcg subcutaneous injection once daily. Nasal route preferred for faster CNS delivery. Typical course: 2–4 weeks acute, 3 months maintenance.
When to Expect Results
Day 1–3: reduced anxiety and improved emotional regulation. Week 1–2: enhanced focus, memory consolidation, and stress resilience. Week 3–6: sustained cognitive improvement and mood stabilization. Long-term: improved BDNF levels and neuroprotection.

Semax 9mg
ACTH-derived nootropic — BDNF boost, focus & neuroprotection
Full Details & Dosage GuideClinical Uses
- Cognitive enhancement and neuroplasticity
- Post-stroke neurological recovery
- ADHD and executive function support
- Ischemic brain injury rehabilitation
- Depression and apathy
- Neuroprotection against chronic stress
Key Benefits
- Rapidly elevates BDNF — the brain's key neuroplasticity signal
- Approved drug in Russia for stroke and neurodegenerative diseases
- Improves working memory, focus, and processing speed
- Antidepressant effect without weight gain or sexual dysfunction
- Neuroprotective against oxidative stress and excitotoxicity
How It Works
Semax is a synthetic heptapeptide analog of ACTH(4-7)PGP. It dramatically upregulates BDNF, NGF, and VEGF in the hippocampus and prefrontal cortex, and modulates serotonergic, dopaminergic, and cholinergic transmission — improving signaling efficiency across neural networks involved in learning, memory, and mood.
Dosage Protocol
300–600 mcg intranasal spray 1–2x daily. 1–2 drops per nostril (300 mcg per nostril). Also available subcutaneously at 100–300 mcg once daily. Nasal route preferred. 2 weeks on, 2 weeks off for cognitive enhancement.
When to Expect Results
Day 1–3: improved focus and mental clarity. Week 1–2: enhanced memory and cognitive endurance. Week 3–4: measurable improvement in executive function. Weeks 4–8: neuroprotective BDNF elevation sustained.

Semax 30mg
Nasal Semax — cognitive performance & neuroplasticity
Full Details & Dosage GuideClinical Uses
- Cognitive enhancement and neuroplasticity
- Post-stroke neurological recovery
- Advanced neuroprotection protocols
- Depression and apathy
- ADHD and executive function support
Key Benefits
- Extended supply for continuous neuroprotective protocols
- Rapidly elevates BDNF — the brain's key neuroplasticity signal
- Improves working memory, focus, and processing speed
- Antidepressant effect without weight gain or sexual dysfunction
- Approved drug in Russia for stroke and neurodegenerative diseases
How It Works
Same Semax mechanism: ACTH(4-7)PGP analog that upregulates BDNF/NGF/VEGF and modulates monoamine neurotransmission. 30mg vial enables extended 8–12 week protocols without interruption.
Dosage Protocol
300–600 mcg intranasal 1–2x daily. 30mg vial supports 2–3 month continuous protocols. Nasal route preferred. 2 weeks on, 2 off for cognitive enhancement; continuous for neuroprotection under physician supervision.
When to Expect Results
Day 1–3: improved focus. Week 1–2: memory and cognitive endurance enhanced. Weeks 3–4: executive function improvement. Weeks 4–12: sustained neuroprotective BDNF elevation.

Semax + Selank 30mg + 30mg
Combined nasal stack — peak cognitive function & anxiety relief
Full Details & Dosage GuideClinical Uses
- Generalized anxiety disorder
- Cognitive performance enhancement
- Memory consolidation and learning
- Post-stress neurological recovery
- ADHD-like focus and attention deficits
- Mild depression support
Key Benefits
- Anxiolytic without sedation — anxiety reduction with full mental clarity
- Enhances BDNF (brain-derived neurotrophic factor) production
- Improves working memory and verbal fluency
- Modulates serotonin and dopamine balance without dependency
- Non-habit-forming with no withdrawal syndrome
- Compatible with long-term use in clinical trials
How It Works
Selank is a synthetic hexapeptide analog of tuftsin. It acts on the benzodiazepine-GABA receptor complex to produce anxiolytic effects without sedation or tolerance. It also upregulates BDNF expression, increases enkephalin degradation (reducing anxiety signals), and modulates serotonin, dopamine, and norepinephrine balance.
Dosage Protocol
250–500 mcg intranasal spray 2–3x daily. Alternatively: 250–500 mcg subcutaneous injection once daily. Nasal route preferred for faster CNS delivery. Typical course: 2–4 weeks acute, 3 months maintenance.
When to Expect Results
Day 1–3: reduced anxiety and improved emotional regulation. Week 1–2: enhanced focus, memory consolidation, and stress resilience. Week 3–6: sustained cognitive improvement and mood stabilization. Long-term: improved BDNF levels and neuroprotection.

Dihexa 2.5mg
Potent nootropic — synaptic growth, memory & cognitive repair
Full Details & Dosage GuideClinical Uses
- Severe cognitive decline and early dementia
- Post-TBI neuroregeneration
- Advanced cognitive enhancement
- Neuroplasticity restoration after chronic stress or addiction
Key Benefits
- Estimated to be 10 million times more potent than BDNF itself
- Stimulates new synapse formation (synaptogenesis)
- Reverses cognitive deficits in animal models of neurodegeneration
- Crosses the blood-brain barrier effectively
- Long-lasting effects persisting weeks after cessation
How It Works
Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) potently activates the HGF/MET signaling pathway in the brain, critical for synaptogenesis and neuronal survival. Estimated 10,000,000x more potent than BDNF at inducing synaptogenesis, explaining profound cognitive effects at microgram doses.
Dosage Protocol
2.5 mg subcutaneous injection 2–3x per week. Starting dose — assess for 2 weeks before any increase. Cycle: 4–6 weeks on, 6–8 weeks off. Never run continuously. Physician monitoring required.
When to Expect Results
Week 1–2: subtle improvements in word recall and pattern recognition. Week 2–4: significant cognitive enhancement and faster learning. Post-cycle: effects persist 2–4 weeks due to lasting synaptic remodeling.

Dihexa 10mg
High-dose Dihexa — advanced neuroregeneration protocol
Full Details & Dosage GuideClinical Uses
- Severe cognitive decline and early dementia
- Post-TBI neuroregeneration
- Alzheimer's disease support
- Advanced cognitive enhancement
- Neuroplasticity restoration
Key Benefits
- Estimated 10 million times more potent than BDNF
- Stimulates synaptogenesis (new synapse formation)
- Reverses cognitive deficits in neurodegeneration models
- Crosses the blood-brain barrier
- Long-lasting effects weeks after cessation
How It Works
Dihexa potently activates HGF/MET signaling in the brain. This pathway is critical for synaptogenesis and neuronal survival. The 10mg vial provides extended protocol supply at 2.5–5 mg doses, enabling full 4–6 week cycles.
Dosage Protocol
2.5–5 mg subcutaneous injection 2–3x per week. 10mg vial provides 2–4 full cycles. Physician monitoring required throughout. 4–6 weeks on, 6–8 weeks off.
When to Expect Results
Week 1–2: cognitive clarity improvement. Week 2–4: significant enhancement and faster learning. Post-cycle: lasting synaptic remodeling maintains effects 2–4 weeks.

Dihexa 20mg
Maximum-strength Dihexa for severe cognitive decline
Full Details & Dosage GuideClinical Uses
- Long-term cognitive decline management
- Post-TBI rehabilitation
- Advanced neuroplasticity protocols
- Alzheimer's disease adjunct support
Key Benefits
- Largest supply vial for extended neuroprotective programs
- 10 million times more potent than BDNF
- Sustained synaptogenesis across multiple treatment cycles
- Physician-supervised long-term CNS protocols
- Lasting cognitive effects between cycles
How It Works
Same Dihexa HGF/MET synaptogenesis mechanism. 20mg vial provides extended multi-cycle supply for serious neurodegenerative or neurorehabilitation protocols under specialist oversight.
Dosage Protocol
2.5–5 mg subcutaneous injection 2–3x per week. 20mg vial supports 4–8 complete cycles. Mandatory physician monitoring. Never continuous — always cycle with equal rest periods.
When to Expect Results
Cumulative benefit across cycles: progressive synaptogenesis and cognitive improvement over months. Each cycle: 2–4 weeks of effect with persistent post-cycle benefit.
All peptides require UAE licensed physician review and mandatory blood work before dispensing. All protocols are subject to physician approval. Results vary by individual. These statements are for informational purposes only and do not constitute medical advice.